Early Tumor Shrinkage as a Predictive Factor for Outcomes in Hepatocellular Carcinoma Patients Treated with Lenvatinib: A Multicenter Analysis

We investigated the association between early tumor shrinkage (ETS) and treatment outcome in patients with hepatocellular carcinoma treated with lenvatinib (LEN). A retrospective analysis was performed in 104 patients. ETS was defined as tumor shrinkage at the first evaluation in the sum of target l...

Descripción completa

Detalles Bibliográficos
Autores principales: Takahashi, Aya, Moriguchi, Michihisa, Seko, Yuya, Shima, Toshihide, Mitsumoto, Yasuhide, Takashima, Hidetaka, Kimura, Hiroyuki, Fujii, Hideki, Ishikawa, Hiroki, Yo, Takaharu, Ishiba, Hiroshi, Morita, Atsuhiro, Jo, Masayasu, Nagao, Yasuyuki, Arai, Masahiro, Hara, Tasuku, Okajima, Akira, Muramatsu, Akira, Yoshinami, Naomi, Nakajima, Tomoki, Mitsuyoshi, Hironori, Umemura, Atsushi, Nishikawa, Taichiro, Yamaguchi, Kanji, Okanoue, Takeshi, Itoh, Yoshito
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7140019/
https://www.ncbi.nlm.nih.gov/pubmed/32209994
http://dx.doi.org/10.3390/cancers12030754

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7140019/
https://www.ncbi.nlm.nih.gov/pubmed/32209994
http://dx.doi.org/10.3390/cancers12030754

Ejemplares similares